Home
Conditions
Myelodysplastic Syndrome

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

NCT01338987

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +25 more
Locations: Childrens National Medical Center Washington D.C., District of Columbia, United States

National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

University of Oklahoma Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation

NCT00620633

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Combined Haploidentical-Cord Blood Transplantation for Adults and Children

NCT00943800

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +18 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia

NCT00469014

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome

NCT00469144

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

NCT01930162

Conditions: Acute Lymphocytic Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +32 more
Locations: Novartis Investigative Site Minneapolis, Minnesota, United States

View Trial Details

Completed

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

NCT01474681

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +51 more
Locations: Novartis Investigative Site Minneapolis, Minnesota, United States

View Trial Details

Completed

Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

NCT00831766

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Cleveland Clinic - Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Completed

Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

NCT01249820

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, Netherlands

View Trial Details

Completed

Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML)

NCT00067028

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Myelodysplastic Syndrome

Myelodysplastic Syndrome trial results

Related conditions